CAS RN: 119793-66-7
Propionyl-L-carnitine Hydrochloride
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20251024
1g / 5g / 25g
Confirm by inquiry
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 119793-66-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥97%
0
Out of Stock
Shenzhen
Inquiry
119793-66-7 / [(2R)-3-carboxy-2-propanoyloxypropyl]-trimethylazanium chloride
Levocarnitine propionate hydrochloride | Dromos | Levocarnitine propionate HCl
Standard CAS: 119793-66-7
Multi CAS: Yes
Basic Information
copy
CAS
119793-66-7 copy
Multi CAS
Yes copy
Molecular Formula
C10H20ClNO4 copy
Molecular Weight
253.720000 copy
Exact Mass
253.108086 copy
SMILES
CCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-] copy
InChI
InChI=1S/C10H19NO4.ClH/c1-5-10(14)15-8(6-9(12)13)7-11(2,3)4;/h8H,5-7H2,1-4H3;1H/t8-;/m1./s1 copy
InChIKey
KTFMPDDJYRFWQE-DDWIOCJRSA-N copy
Synonyms
Levocarnitine propionate hydrochloride
Dromos
Levocarnitine propionate HCl
ST 261
UNII-12FW2YBF04 copy
Computed Properties
copy
Structural Parameters
Heavy atom count
16 copy
Fraction Csp3
0.8 copy
Rotatable bonds
6 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
55.32 copy
TPSA
63.6 copy
LogP / Solubility
WLOGP
-2.51 copy
MLOGP
-2.2 copy
XLogP3
-2.51 copy
Consensus LogP
-2.41 copy
Log S (ESOL)
0.56 copy
Class (ESOL)
Highly soluble copy
Log S (Ali)
0.17 copy
Class (Ali)
Highly soluble copy
Log S (SILICOS-IT)
0.05 copy
Class (SILICOS-IT)
Highly soluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-6.05 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
Yes copy
Synthetic Accessibility
2 copy
Safety & Transport
copy
Pictogram(s)
Irritant copy
Signal
Warning copy
GHS Hazard Statements
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
Not Classified
Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website. copy
Precautionary Statement Codes
P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 copy